Rheumatic Diseases (Rheumatism)

4747 relevant articles (144 outcomes, 407 trials/studies) found for this Disease

Description: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.

Also Known As:

Rheumatism; Enthesopathies; Enthesopathy; Disease, Rheumatic; Diseases, Rheumatic; Rheumatic Disease

Subscribe to New Research on Rheumatic Diseases

Relationship Network

Disease Context: Research Results

Musculoskeletal Diseases: 82

Rheumatic Diseases: 4747

Rheumatoid Arthritis: 26878

Osteoarthritis: 8815

Gout: 2228

Rheumatic Fever: 1364

Fibromyalgia: 1016

Polymyalgia Rheumatica: 395

Sternocostoclavicular Hyperostosis: 8

Skin and Connective Tissue Diseases

Connective Tissue Diseases: 1616

Rheumatic Diseases: 4747

Rheumatoid Arthritis: 26878

Polymyalgia Rheumatica: 395

Sternocostoclavicular Hyperostosis: 8

Related Diseases

1.	Pain (Aches)
2.	Rheumatoid Arthritis
3.	Ankylosing Spondylitis
4.	Inflammation
5.	Arthritis (Polyarthritis)
408 Diseases and 1319 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Rheumatic Diseases:

1.	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/01/1995 - "Nonsteroidal anti-inflammatory drugs (NSAIDs) are the mainstay of treatment for rheumatic diseases" 09/01/2000 - "Available clinical studies suggest, but do not document, equivalent efficacy of topical over oral NSAIDs in rheumatic diseases." 01/01/2001 - "AIMS: The efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) in rheumatic diseases depends on their concentrations within the joint" 01/01/2007 - "Open clinical studies and randomised, placebo- or verum-controlled double-blind trials, performed in different subtypes of rheumatic diseases, confirm the pharmacological evidence of efficacy, such as by reducing the intake of non-steroidal antiinflammatory drugs (NSAIDs)" 12/01/1996 - "However, based on the results of this study, topical therapy with NSAIDs can be recommended for soft tissue rheumatism and periarticular insertion tendinopathia." Get all the results and reference details, order at left...
2.	infliximab (Remicade)FDA Link 11/01/2002 - "These remarkably positive results have led to the investigation of infliximab treatment for other rheumatic diseases" 01/01/2007 - "Short Form Health Survey-36 (SF-36) data from the placebo-controlled phases of 4 studies of infliximab in patients with inflammatory rheumatic diseases (n = 1990) were evaluated" 01/01/2008 - "Infliximab was infused according to the domestically approved method, and the clinical response was evaluated following 54 weeks of infliximab therapy using the European League Against Rheumatism (EULAR) response criteria" 01/01/2008 - "METHODS: All (n = 104) RA and SpA patients who were treated with infliximab as their first biological treatment according to the national guidelines in the Centre for Rheumatic Diseases, Tampere University Hospital during 1999-2005 were analysed at baseline and after 6 months of treatment" 11/01/2007 - "For patients who started with TNFalpha-neutralising (infliximab) or GC treatment, courses with a duration of at least 3 months were included and response to TNFalpha blockers or GC was calculated according to the European League Against Rheumatism response criteria" Get all the results and reference details, order at left...
3.	TNFR-Fc fusion protein (etanercept)FDA Link 01/01/2004 - "Anticytokine biologics have demonstrated great promise in the treatment of JRA and a variety of other pediatric rheumatic diseases, although at this time the randomized, placebo-controlled data are limited only to etanercept in children with polyarticular JRA" 02/01/2002 - "This study evaluated the long-term safety and tolerability of open-label use of etanercept when used to treat patients with a variety of systemic rheumatic diseases" 04/15/2007 - "Disease Activity Score in 28 joints (DAS28), European League Against Rheumatism (EULAR) response, and American College of Rheumatology (ACR) response were determined after 12 weeks of etanercept" 03/01/2006 - "Long term safety of etanercept in elderly subjects with rheumatic diseases." 01/01/2006 - "The clinical application of etanercept in Chinese patients with rheumatic diseases." Get all the results and reference details, order at left...
4.	Antirheumatic Agents (DMARD)IBA 01/01/2007 - "Few disease modifying anti-rheumatic drugs (DMARDs) have been available due to a lack of efficacy of most of the DMARDs used for other rheumatic diseases" 05/01/2002 - "These observations are germane to observational studies of disease modifying antirheumatic drugs and biologics, as well, and suggest the need for careful control of confounders when assessing treatment effects in rheumatic disease observational studies." 10/01/2007 - "The high prevalence of inflammatory rheumatic diseases in women of childbearing age increases the risk of exposure to antirheumatic agents during conception pregnancy and breast feeding" 09/01/2007 - "It requires: 1) the strict evaluation of the potential risks of flare of the rheumatic disease because of the pregnancy; 2) the assessment of risks on pregnancy outcome and fetus development; 3) the management of the different anti-rheumatic agents in order to maintain optimal control of disease activity and avoid any teratogenic problem" 10/01/2005 - "Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs." Get all the results and reference details, order at left...
5.	Diclofenac (SR 38)FDA LinkGeneric 10/13/1978 - "Therapeutic efficacy and tolerance of a new drug, sodium diclofenac, in inflammatory and metabolic rheumatism]" 10/01/1988 - "A study of individual response factors to the anti-inflammatory drug Diclofenac, as carried out in 3,123 patients, selected by 200 french rheumatism specialists" 01/01/1979 - "The efficacy and tolerability of diclofenac was studied in an initial two-week assessment study in 24 patients with rheumatic disease" 03/05/1976 - "Clinical experiences and results of clinical experimental studies with Voltaren in rheumatic diseases]" 05/01/1996 - "Diclofenac is widely used in the treatment of rheumatic diseases and is mainly metabolized in the liver by CYP2C9" Get all the results and reference details, order at left...
6.	Methotrexate (Mexate)FDA LinkGeneric 03/01/1991 - "Low dose methotrexate has been used effectively for various rheumatic and non-rheumatic diseases" 12/01/1985 - "This paper will review the findings of the Cooperating Clinics of the American Rheumatism Association, as well as other studies that have investigated the short term efficacy of methotrexate." 01/01/1994 - "This parameter was correlated with other clinical observations obtained during a prospective, randomized, placebo-controlled trial of methotrexate, sponsored by the Cooperative Systematic Studies of Rheumatic Diseases consortium" 09/01/2006 - "Methotrexate has been used as an important alternative therapy in the treatment of various rheumatic diseases" 04/01/2005 - "Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria." Get all the results and reference details, order at left...
7.	Naproxen (Naprosyn)FDA LinkGeneric 01/01/2004 - "In the present investigation we studied the effect of naproxen, a non-steroidal anti-inflammatory drug used for the treatment of rheumatic disease, on the synthesis of the lepidotrichial matrix of the tail fin of the teleost fish Cyprinus carpio (carp) during the regeneration process" 01/01/1990 - "Naproxen--standard in rheumatism therapy" 03/01/1986 - "We conclude that oral treatment with naproxen has an immunomodulatory effect and improves in vitro PHA-induced proliferation of lymphocytes from rheumatic disease patients" 03/01/1986 - "Oral treatment for 7 days with naproxen also resulted in a significant enhancement of the in vitro PHA-induced proliferation of lymphocytes from RA patients and from age-matched control patients with noninflammatory rheumatic diseases, but not from young healthy controls" 03/01/1986 - "Immunomodulatory effects of treatment with naproxen in patients with rheumatic disease." Get all the results and reference details, order at left...
8.	Carbon MonoxideIBA 11/01/2007 - "Preventive services, acute care, management of chronic co-morbidities, and rheumatology care for rheumatic disease patients can only be accomplished through the close integration of multiple practices and other health system resources" 03/01/2008 - "OBJECTIVE: To estimate and compare the observed and expected prevalence of the co-existence of rheumatic diseases (RD) with other chronic conditions" 12/01/2006 - "There were 8 plenary lectures and 4 symposia and the AAF provided an excellent avenue to promote the co-ordination and knowledge exchange in the area of autoimmune rheumatic diseases in Asia." 09/01/2006 - "Frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases]" 09/01/2006 - "What is the frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases?]" Get all the results and reference details, order at left...
9.	AntibodiesIBA 05/01/2007 - "These antibodies are safe and effective in the long-term therapy of many rheumatic diseases" 04/01/2002 - "A number of studies have found increased levels of antibodies to human endogenous retroviruses (HERVs) in autoimmune rheumatic diseases" 01/01/1995 - "The aim of the study was to assess the significance of type 2 anti-mitochondrial antibodies in patients with systemic and inflammatory rheumatic disease" 06/01/1994 - "This study demonstrates that: 1) ANoA are uncommon in unselected sera although use of a cell line substrate doubles the rate of positivity; 2) the proper HEp-2 substrate is critical in the detection of ANoA; 3) PSS and SLE are the most frequent diseases associated with ANoA but the frequency of these antibodies in SLE patients was very low.; 4) there are 3 distinct nucleolar staining patterns which may be associated with different rheumatic diseases; and 5) compared with ANoA negative scleroderma, clumpy nucleolar staining had significantly higher incidence in men with no joint involvement but a tendency towards more lung manifestations." 04/15/1987 - "This study has identified a new marker, antibodies against a nuclear RNP protein of 56 KD for detecting muscle involvement among the autoimmune rheumatic diseases." Get all the results and reference details, order at left...
10.	AntigensIBA 01/01/1987 - "The study of sixty-five children with antigen HLA B27 associated chronic rheumatism was performed" 01/01/1977 - "Study on the effect of antirheumatic therapy on the indices of the leukocyte migration inhibition test using myocardial cell membrane antigens in patients with rheumatism]" 04/01/1967 - "A study of the antigen stimulation of patients with rheumatism and its comparison with clinical aspects, degree of activity, and results of treatment]" 07/01/1963 - "STUDY OF THE ANTIGENS FROM THE SERUM OF CHILDREN WITH BOUILLAUD-SOKOLSKI RHEUMATISM, USING THE IMMUNOELECTROPHORETIC METHOD.]" 01/01/1957 - "Study of biological tests in rheumatic disease; changes in the leukogram and erythrocyte sedimentation rate after intradermal injection of streptococcal antigen.]" Get all the results and reference details, order at left...
1226 Drugs and Important Bio-Agents and 4243 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Therapies and Procedures

1.	Transplantation (Transplant Recipients) 12/01/2000 - "Data from all transplanted patients are being collated in a centralized register by the European Group for Blood and Marrow Transplantation (EBMT) and the European League against Rheumatism (EULAR) to enable effective evaluation of the safety and efficacy of this promising technique" 01/01/2004 - "The European Group for Blood and Marrow Transplantation (EBMT) and The European League Against Rheumatism (EULAR) have analysed their collective phase I and II studies and found a remission rate (based on a reduction of the SLEDAI to < 3) in 66%, one-third of whom later relapsed to some degree" 12/01/2001 - "Based on a concept statement issued in 1995, two European societies, the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT) began collecting phase I/II trial data in an international collaborative network" 11/01/2007 - "The changes of both clinical manifestations and immunologic indexes were observed before and after transplantation with long term following up at specialty clinic of rheumatism" 01/01/2004 - "All patients were registered in the European Group for Blood and Marrow Transplantation (EBMT)/European League Against Rheumatism (EULAR) database" Get all the results and reference details, order at left...
2.	Mud Therapy (Mud Bath) 11/01/1981 - "Quantitative relation between the efficacy of mud therapy and weather changes in patients with rheumatic diseases]" 01/01/2003 - "Fangotherapy in chronic degenerative rheumatic diseases]" 08/01/2002 - "Mud pack therapy is an alternative mode of treatment for rheumatic diseases" 11/01/1993 - "Effects of thermal balneo-fangotherapy on extra-articular rheumatic diseases in relation to sports activity]" 07/01/1985 - "Effect of mud therapy on the cardiovascular system in children with rheumatism]" Get all the results and reference details, order at left...
3.	Complementary Therapies (Alternative Medicine) 05/01/1999 - "Research on complementary medicine in rheumatic diseases: the need for better quality studies and reproduction of claimed positive results." 02/23/1991 - "It is necessary to perform further studies on the effect of frequently used types of complementary medicine in patients with rheumatic diseases, by or in cooperation with the physicians or paramedics who prescribe or perform these kinds of treatment" 04/15/2001 - "Patients with rheumatic disease are turning to complementary and alternative therapies in growing numbers" 04/15/2001 - "Complementary and alternative therapies for rheumatic disease." 03/01/2001 - "OBJECTIVE: To determine how frequently herbal remedies are employed as alternative therapies in rheumatic diseases, and the historical justification for their use" Get all the results and reference details, order at left...
4.	Stem Cell Transplantation 01/01/1999 - "Preclinical studies and anecdotal case reports suggest that high-dose immunosuppressive therapy supported by stem cell transplantation may lead to remissions or even cure in various experimental disease models of autoimmunity as well as in some human rheumatic diseases" 09/01/2005 - "Hemopoietic stem cell transplantation in rheumatic diseases--an update." 10/01/2001 - "Autologous stem cell transplantation for pediatric rheumatic diseases." 01/01/1999 - "This review attempts to summarize some preclinical and clinical data on stem cell transplantation in the treatment of severe rheumatic diseases" 01/01/1999 - "Stem cell transplantation--a treatment for severe rheumatic diseases?--A review." Get all the results and reference details, order at left...
5.	Balneology 10/01/1999 - "The efficacy of balneotherapy at the Dead Sea area for the treatment of degenerative rheumatic diseases has not yet been formally evaluated" 02/01/2004 - "METHOD: The studies which have been conducted between 1990 and 2000 in different spas in Turkey on the efficacy and effectiveness of spa therapy and balneotherapy for rheumatic diseases have been searched and analyzed independent of their design" 04/01/2006 - "This review provides an overview of the known as well as the novel aspects of balneotherapy and their clinical relevance in the treatment of rheumatic diseases." 04/01/2006 - "Balneotherapeutic applications to treat rheumatic diseases have a long-term tradition and are based on established scientific principles, and the majority of rheumatic diseases most frequently include balneotherapy" 04/01/2006 - "Balneotherapy in rheumatic diseases--an overview of novel and known aspects." Get all the results and reference details, order at left...
130 Therapies and Procedures and 636 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Patient-Physician Research Summary Report on Rheumatic Diseases

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 144 Outcomes
Top 200 Key Medications
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF for "Psoriasis" >>

Price:

$24.00 & Delivery via PDF download,
updates for 1 year

Proceed to Checkout >>

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>